Srinivas Sridhar

SCIENTIST

INNOVATOR

EDUCATOR

LEADER

HTML Layer

Research Areas

Cancer Research

Superconductivity

Nanomedicine

Nanoparticles

Experimental Mathematics

Quantum Chaos

Neurotechnology

Nanophotonics

Quantitative MRI

INNOVATIVE EDUCATION AND TRAINING PROGRAMS

Srinivas Sridhar

A LIFELONG COMMITMENT TO EDUCATION OF UNDER-REPRESENTED MINORITIES

2016 BIOMEDICAL ENGINEERING SOCIETY DIVERSITY AWARD

INNOVATOR

ENTREPRENEUR

TRANSLATING NANOMEDICINES TO THE CLINIC

Founder

MOBILE VISION AND BRAIN HEALTHCARE

Professor Srinivas Sridhar

Srinivas Sridhar is University Distinguished Professor of Physics, Biomedical Engineering and Chemical Engineering at Northeastern University, and Lecturer on Radiation Oncology, Harvard Medical School. He is the Director and Principal Investigator of Nanomedicine Academy and the NIH CaNCURE programs, and the founding director of the Nanomedicine Innovation Center, an interdisciplinary center with research and education thrusts in nanomedicine, nanomaterials and neurotechnology. From 2004 to 2008 he served as Vice Provost for Research at Northeastern University, overseeing the University’s research portfolio. He is an elected Fellow of the American Physical Society, and Fellow of the American Institute of Medical and Biological Engineering.  Sridhar’s current areas of research are nanomedicine, neurotechnology and Quantitative MRI. His paper in Nature in 2003 was listed among Breakthroughs of 2003 by the journal Science. He has published more than 450 journal articles, patents and technical reports on his work in nanomedicine, neurotechnology, nanophotonics, metamaterials, quantum chaos, superconductivity and collective excitations in materials. A dedicated teacher and mentor, he was honored with the 2016 Biomedical Engineering Society Diversity award.

Recent Publications

Baldwin, Paige; Sridhar, Srinivas; Singh, Bijay

Nanoencapsulated combination drug formulations Miscellaneous

2023, (US Patent 11,648,211).

Tags: Nanomedicine

Sridhar, Srinivas

True superconductivity at near ambient temperature has not been confirmed by Dasenbrock-Gammon, et. al. Nature (2023) Journal Article

In: arXiv preprint arXiv:2303.05987, 2023.

Tags:

Yang, Shicheng; Green, Allen; Brown, Needa; Robinson, Alexis; Senat, Merline; Testino, Bryanna; Dinulescu, Daniela M; Sridhar, Srinivas

Sustained delivery of PARP inhibitor Talazoparib for the treatment of BRCA-deficient ovarian cancer Journal Article

In: Frontiers in Oncology, vol. 13, pp. 1175617, 2023.

Tags: Nanomedicine

View All Publications

Education and Training

  • 1200

    STUDENTS TAUGHT AND MENTORED

    BS, MS, PHD STUDENTS TAUGHT

    FACULTY AND SCIENTISTS MENTORED

  • 5

    NANOMEDICINE COURSES DEVELOPED

    INTRO TO NANOMEDICINE

    NANOMEDICINE COMMERCIALIZATION

    NANOMEDICINE SEMINAR

    RESEARCH TECHNIQUES IN NANOMEDICINE

  • $9M

    TRAINING GRANTS

    2 NSF IGERT NANOMEDICINE GRANTS

    NIH R25 CANCURE GRANT

    NSF NANOMEDICINE ACADEMY

  • 1

    DIVERSITY AWARD

    DIVERSITY AWARD

    BIOMEDICAL ENGINEERING SOCIETY

  • 14

    PHDS MENTORED

    PHYSICS

    BIOMEDICAL ENGINEERING

    MECHANICAL AND INDUSTRIAL ENGINEERING

    CHEMICAL ENGINEERING

© Copyright Sridhar Lab. All rights reserved.